GH Research's inhaled psychedelic therapy GH001 has shown promise in a mid-stage trial in treatment-resistant depression (TRD), sending its shares soaring and prompting a $150 million offering to ...
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company provides precision oncology testing services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback